FDA’s Failure To Regulate CBD Is Health Threat, Says U.S. House Committee Chair
James Comer called upon congress to set a legislative framework for regulations
The U.S. Food & Drug Administration’s (FDA) failure to regulate CBD leaves the door open for nefarious business operators, and threatens consumers’ health, the chairman of a key congressional committee has warned the agency.
In a letter last week, Rep. James Comer, a Kentucky Republican who is Chairman of the House Committee on Oversight and Accountability, criticized the FDA’s announcement earlier this year that declared federal safety standards are insufficient to manage the CBD industry. The agency said not enough is known about CBD products to regulate them as foods or supplements under the FDA’s current structure, and called on Congress to set a legislative framework for regulations.
“FDA’s claim of a lack of a regulatory pathway is not only an insufficient rationale for inaction, but it is directly affecting the welfare of the American public,” Comer said in the letter, which was addressed to Robert Califf, FDA’s Commissioner of Food and Drugs
“The lack of regulation of non-intoxicating CBD products have allowed for potentially dangerous products to enter the market in the form of delta-8 and other hemp-derived intoxicants, leading to increasing concern that some products contain potentially dangerous ingredients due to the lack of regulation,” Comer said in the letter.
“Proper regulation from the FDA would not only prevent bad faith actors from entering the market but will increase the amount of good faith manufacturers’ contributions of a useful product for the American public,” Comer wrote.
To Read The Rest Of This Article On Hemp Today, Click Here